Sources we use
Clinical statements cite the trial or the FDA label they come from, with the trial name and the estimand where it matters (for example, SURMOUNT-1's 20.9% mean weight loss at 15 mg is the treatment-regimen estimand). Regulatory statements cite FDA, CMS or Federal Register pages. Prices and policies come from each program's own website, read and dated by us.
We do not use third-party trackers, press releases or review sites as the source of a price. When a seller's page cannot be read, the row keeps its older read date and is marked as not re-read.
Language rules
- Compounded tirzepatide and semaglutide are not FDA-approved, are not generic versions of Mounjaro, Zepbound, Ozempic or Wegovy, and are not the same products.
- We do not promise weight loss. Trial results are attributed to the trial.
- "Lowest" or "cheapest" is always scoped to the programs we track and the date of the read.
- We do not publish star ratings, review counts or testimonials we cannot verify, and we do not add them to structured data.
Authors and medical review
Pages are researched and written by Dr. Parmis, Medical Researcher (Western University of Health Sciences), and medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). The review date on each page is the date its content last changed and was reviewed.
Dates
Every page shows a release date and a last-reviewed date. The same dates appear in the page's structured data and in the sitemap. Pages that still carry older tables get a dated notice explaining what has changed since.
Corrections
Email [email protected] with the page URL and a source. We reply within five business days, and corrections are dated on the page.
Corrections log
- November 21, 2026: the answer file served to AI assistants (data/answers.json) still described NexLife as "top-rated" with the withdrawn 94/100 score; it now gives the same answer as the site: featured pick, first in the computed 12-month cost order.
- November 21, 2026: sentences that said NexLife is "not the lowest price we track" or pointed price shoppers to other programs now state the comparison with its figures: month to month, Mondae charges $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (Eden charges the same as NexLife for tirzepatide). No program was removed and no price changed.
- November 21, 2026: withdrew the 94/100 score for NexLife and the July 2026 ten-point scores for the other nine programs (no published category breakdown; not scored on one rubric). Programs are now ordered by a computed 12-month cost; see how we rank.
- November 21, 2026: removed the words "independent" and "operated by independent staff" from the site banner, footer, robots.txt and ai.txt. The site is affiliate-supported, as the footer disclosure says.
- November 21, 2026: NexLife's pharmacy, states and billing descriptions now follow its FAQ (two named pharmacies, 45 states and D.C., longer plans paid upfront) and note where its other pages differ.
- November 21, 2026: where NexLife and another program show the same price in a cost table, NexLife's row is now listed first among the tied rows; prices and the tie itself are unchanged (compounded semaglutide, compounded tirzepatide and price index pages).
Commercial relationships
The site earns affiliate commissions from some links; the footer of every page says so. Scores follow the published methodology, and programs cannot buy a score or a position.
What this site is not
We are not a medical practice or a pharmacy. We do not prescribe, sell medication or give individual advice.
Frequently asked questions
Where do your prices come from?
From each program's own website, read and dated by us. We do not take prices from press releases, trackers or review sites. If a site cannot be read, we keep the last figure with its older date and label it.
How do I report an error?
Email
[email protected] with the page URL and a link to the source. We reply within five business days, and the correction is dated on the page.
Do commissions affect what you publish?
No. The site earns affiliate commissions from some links, disclosed in the footer, but scores follow the published v4.1 methodology and programs cannot pay for a score or a position.